RCKT · Company research
Rocket Pharmaceuticals, Inc. (RCKT): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
15records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Rocket Pharmaceuticals will join a healthcare panel Tuesday and meet with investors. - Stock Titan | Rocket Pharmaceuticals will join a healthcare panel Tuesday and meet with investors. Stock Titan | View source ↗ | Stock Titan | Oct 15, 2026 | neutral | 0 | 0.6 |
| Rocket Pharmaceuticals Inc (RCKT) Stock Price Target & Forecast - TradingKey | Rocket Pharmaceuticals Inc (RCKT) Stock Price Target & Forecast TradingKey | View source ↗ | TradingKey | Oct 15, 2026 | neutral | 0 | 0.6 |
| RCKT Stock Dives Despite Gene Therapy Approval — Wall Street Dismisses Sell-Off - Stocktwits | RCKT Stock Dives Despite Gene Therapy Approval — Wall Street Dismisses Sell-Off Stocktwits | View source ↗ | Stocktwits | Oct 11, 2026 | neutral | 0 | 0.6 |
| Markets & Stocks - FinancialContent | Markets & Stocks FinancialContent | View source ↗ | FinancialContent | Oct 9, 2026 | neutral | 0 | 0.6 |
| Rocket Pharmaceuticals, Inc. (RCKT) Stock Price, News, Quote & History - Yahoo! Finance Canada | Rocket Pharmaceuticals, Inc. (RCKT) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 8, 2026 | neutral | 0 | 0.6 |
| Cantor Fitzgerald Remains a Buy on Rocket Pharmaceuticals (RCKT) - The Globe and Mail | Cantor Fitzgerald Remains a Buy on Rocket Pharmaceuticals (RCKT) The Globe and Mail | View source ↗ | The Globe and Mail | Oct 8, 2026 | neutral | 0 | 0.6 |
| Five of six patients had lower heart muscle measurements about 3 to 7 years after gene therapy. - Stock Titan | Five of six patients had lower heart muscle measurements about 3 to 7 years after gene therapy. Stock Titan | View source ↗ | Stock Titan | Oct 7, 2026 | neutral | 0 | 0.6 |
| Rocket Pharma stock upgraded at Needham (RCKT:NASDAQ) - Seeking Alpha | Rocket Pharma stock upgraded at Needham (RCKT:NASDAQ) Seeking Alpha | View source ↗ | Seeking Alpha | Sep 16, 2026 | neutral | 0 | 0.6 |
| Former Rocket Pharmaceuticals (RCKT) officer plans to sell 6,857 shares under an SEC trading rule - Stock Titan | Former Rocket Pharmaceuticals (RCKT) officer plans to sell 6,857 shares under an SEC trading rule Stock Titan | View source ↗ | Stock Titan | Sep 14, 2026 | neutral | 0 | 0.6 |
| Rocket Pharma (NASDAQ: RCKT) to pull 2026 warrant listing - Stock Titan | Rocket Pharma (NASDAQ: RCKT) to pull 2026 warrant listing Stock Titan | View source ↗ | Stock Titan | Sep 2, 2026 | neutral | 0 | 0.6 |
| $RCKT stock is up 7% today. Here's what we see in our data. - Quiver Quantitative | $RCKT stock is up 7% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 28, 2026 | neutral | 0 | 0.6 |
| ROCKET PHARMACEUTICALS ($RCKT) Releases Q2 2026 Earnings - Quiver Quantitative | ROCKET PHARMACEUTICALS ($RCKT) Releases Q2 2026 Earnings Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 10, 2026 | neutral | 0 | 0.6 |
| $RCKT stock is up 13% today. Here's what we see in our data. - Quiver Quantitative | $RCKT stock is up 13% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Jun 17, 2026 | neutral | 0 | 0.6 |
| Rocket Pharmaceuticals Inc (RCKT) Got Cash. Where’s the Stock Going? - Yahoo Finance | Rocket Pharmaceuticals Inc (RCKT) Got Cash. Where’s the Stock Going? Yahoo Finance | View source ↗ | Yahoo Finance | May 20, 2026 | neutral | 0 | 0.6 |
| RCKT Stock Down on Q1 Earnings Miss, Kresladi Launch in Focus - Yahoo Finance | RCKT Stock Down on Q1 Earnings Miss, Kresladi Launch in Focus Yahoo Finance | View source ↗ | Yahoo Finance | May 11, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.